Insecticides, commonly used as a mosquito control measure against diseases such as Zika, may affect the development of motor functions in infants according to new research.
Research presented at ASM Microbe has reported a Zika vaccine based on the NS1 protein can induce protective immunity in mouse models after a single dose.
Author, Mark Woolhouse, discusses recent efforts to identify pathogens with pandemic potential and his own work on emerging viruses.
A new first-of-its-kind study will assess Zika virus as a tool to target glioblastomas, one of the most challenging cancers to treat.
Researchers have utilized LAMP technology to develop a new rapid and sensitive low-cost test for Zika virus; they hope it will allow more effective tracking of disease spread.
Research presented at ECCMID 2017 highlighted the potential of intracellular bacterium Wolbachia to control and prevent arboviruses, including Zika and chikungunya.
In new research, the first live-attenuated Zika vaccine has been demonstrated to protected mice against the virus after a single dose.
Environmental change, and a growing and more connected population will promote vector-borne disease risk further. In this opinion piece, the authors discuss the role of climate modeling in disease prediction and epidemiology.
Researchers have identified the southern states of the USA as most at risk of high burden from Zika virus.
Researchers have determined the full structure of Zika protein NS5; a protein is crucial for viral replication and which could present a target for future drug development.
